Superinfected COVID-19 in a young patient with posterior reversible encephalopathy syndrome: A case report.
Mohammad Javad NasrAli Alizadeh KhatirFatemeh Abedi KebriaBahareh BazooyarSoheil EbrahimpourAzin GooranPublished in: Clinical case reports (2024)
Posterior reversible encephalopathy syndrome (PRES) is a clinical syndrome with central nervous system (CNS) symptoms usually related to autoregulatory cerebral failure and high blood pressure. Neuroimaging is critical to diagnosis. Neurological presentations of COVID-19 disease are categorized into CNS symptoms and peripheral nervous system (PNS) symptoms. The patient was a 15-year-old female with SARS-CoV-2 pneumonia who developed PRES with a typical clinical and radiological appearance. She was treated with dexamethasone, phenytoin, sodium valproate and remdesivir. The patient was discharged after recovery of symptoms and was in good general condition. It is recommended that in patients affected by COVID-19 with neurological symptoms, the PRES can be considered in the differential diagnosis.
Keyphrases
- sars cov
- case report
- coronavirus disease
- blood pressure
- sleep quality
- newly diagnosed
- respiratory syndrome coronavirus
- early onset
- ejection fraction
- low dose
- type diabetes
- prognostic factors
- subarachnoid hemorrhage
- insulin resistance
- intensive care unit
- heart rate
- physical activity
- acute respiratory distress syndrome
- brain injury
- blood glucose